Venetoclax, a cancer drug that inhibits BCL-2, reduced the intact SIV reservoir in macaques, offering preclinical support for targeting BCL-2 as part of HIV cure strategies. The post Cancer Drug Reduces SIV Reservoir in Macaques, May Inform HIV Cure Strategies appeared first on GEN - Genetic Engineering and Biotechnology News .
Cancer Drug Reduces SIV Reservoir in Macaques, May Inform HIV Cure Strategies
Savannah Wiegel